Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
RN624 For Pain Of Post-Herpetic Neuralgia
This study is currently recruiting participants.
Study NCT00568321.   Last updated on January 8, 2009.
Information provided by Pfizer
Please refer to this study by its ClinicalTrials.gov identifier: NCT00568321
Contacts
Contact: Pfizer CT.gov Call Center 1-800-718-1021

Locations
United States, Alabama
Pfizer Investigational Site Completed
Anniston, Alabama, United States, 36207
United States, Arizona
Pfizer Investigational Site Completed
Litchfield Park, Arizona, United States, 85340
Pfizer Investigational Site Completed
Phoenix, Arizona, United States, 85023
United States, Florida
Pfizer Investigational Site Active, not recruiting
Tampa, Florida, United States, 33606
Pfizer Investigational Site Active, not recruiting
Clearwater, Florida, United States, 33765
Pfizer Investigational Site Active, not recruiting
Sunrise, Florida, United States, 33351
Pfizer Investigational Site Completed
Largo, Florida, United States, 33770
Pfizer Investigational Site Active, not recruiting
Palm Beach Gardens, Florida, United States, 33418
Pfizer Investigational Site Active, not recruiting
Atlantis, Florida, United States, 33462
Pfizer Investigational Site Active, not recruiting
Miami, Florida, United States, 33175
United States, Kansas
Pfizer Investigational Site Completed
Topeka, Kansas, United States, 66606
United States, Maryland
Pfizer Investigational Site Active, not recruiting
Towson, Maryland, United States, 21286
United States, Massachusetts
Pfizer Investigational Site Recruiting
N. Dartmouth, Massachusetts, United States, 02747
United States, Michigan
Pfizer Investigational Site Recruiting
Ann Arbor, Michigan, United States, 48104
United States, Minnesota
Pfizer Investigational Site Recruiting
Edina, Minnesota, United States, 55435
United States, Missouri
Pfizer Investigational Site Completed
St Louis, Missouri, United States, 63141
United States, North Carolina
Pfizer Investigational Site Completed
Asheville, North Carolina, United States, 28806
United States, Ohio
Pfizer Investigational Site Completed
Kettering, Ohio, United States, 45429
Pfizer Investigational Site Completed
Cleveland, Ohio, United States, 44122
Pfizer Investigational Site Active, not recruiting
Dayton, Ohio, United States, 45432
United States, Pennsylvania
Pfizer Investigational Site Recruiting
Duncansville, Pennsylvania, United States, 16635-0909
Pfizer Investigational Site Completed
Altoona, Pennsylvania, United States, 16602
United States, Texas
Pfizer Investigational Site Completed
Dallas, Texas, United States, 75230
Pfizer Investigational Site Active, not recruiting
San Antonio, Texas, United States, 78229
Pfizer Investigational Site Completed
Bryan, Texas, United States, 77802
Pfizer Investigational Site Completed
Houston, Texas, United States, 77024
Pfizer Investigational Site Completed
San Antonio, Texas, United States, 78229
United States, Virginia
Pfizer Investigational Site Completed
Richmond, Virginia, United States, 23294
Sponsors and Collaborators
Pfizer
Investigators
Study Director: Pfizer CT.gov Call Center Pfizer




U.S. National Library of Medicine,  Contact Help Desk
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services